Expression of bcl-2, bax, bcl-xl, and bcl-xs in endometrial and cervical tissues

Cancer Detection and Prevention

Volumn 24, Issue 6, 2000, Pages 536-541

  Mozzetti, S ^a   Ferrandina, G ^a   Marone, M ^a   D'Ingiullo, F ^a   Fruscella, E ^a   De Pasqua, A ^a   Mancuso, S ^a   Scambia, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bax; Bcl 2; Bcl xL; Bcl xS

Indexed keywords

BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CARCINOMA; COMPARATIVE STUDY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LEIOMYOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0034487533     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The role of bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumorigenesis and resistance to chemotherapy
2. Apoptosis in the pathogenesis and treatment of disease
3. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation
4. Bcl-x, a bcl-2-related gene that functions as a dominan: Regulator of apoptotic cell death
5. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death
6. Bcl-2 protein expression in cutaneous malignant melanoma and benign melanocytic nevi
7. The bcl-2 protein, a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
8. Bcl-2 protein expression in non-small-cell lung carcinoma
9. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
10. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model
11. s expression in normal and neoplastic ovarian tissues
12. Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma
13. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix
14. Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix
15. Expression of the proto-oncogene bcl-2 in uterine cervical squamous cell carcinoma: Its relationship to clinical outcome
16. Progressing imbalance between proliferation and apoptosis with increasing severity of cervical intraepithelial neoplasia
17. Investigation of bcl-2 and c-myc expression in relationship to the Ki-67 labeling index in cervical intraepithelial neoplasia
18. Elevated expression of bcl-x and bax in primary colorectal adenocarcinomas
19. L and mcl-1 expression in prostate cancer
20. Life, death, and the pursuit of apoptosis
21. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: Glandular epithelial cell apoptosis is associated with increased expression of bax
22. Primitive human hematopoietic precursor express bcl-x but not bcl-2
23. Expression of bcl-2 gene family in malignant breast tissue: Low bax-a expression in tumor cells correlates with resistance towards apoptosis
24. Immunohistochemical analysis of in vivo patterns of Bak expression, a pro-apoptotic member of the bcl-2 protein family